From past innovations like the polio vaccine to current advances in cancer, heart disease, and other illnesses, innovation has saved and improved countless lives.
Innovation: Saves Lives
The Triple Solution for a Healthier America is a three-part approach to tackle chronic diseases, promote a healthier life, and lower healthcare costs by focusing on Prevention, Intervention, and Innovation.

Invest in health and save our healthcare.

The Triple Solution for a Healthier America: Using Prevention to reduce chronic disease, promote a healthier life, and lower healthcare costs of diabetes and other chronic diseases The Triple Solution for a Healthier America: Using Intervention to better manage chronic diseases like type 2 diabetes, promote a healthier life, and lower healthcare costs. The Triple Solution for a Healthier America: Using Innovation to reduce chronic disease and lower healthcare costs. Learn what you can do to reduce chronic disease, lower healthcare costs, and live a healthier life through personal, professional, and political involvement with the Triple Solution for a Healthier America.

Make your voice and opinions heard.
Learn more

Sites For Your Health

GSKforYou.com >>

Find help with prescription costs.


TakingMeds.com >>

Get the most from medicines.


Font Size A A A | Print Page

Innovation Saves Lives

From past innovations like the polio vaccine to current advances in cancer, heart disease, and other illnesses, innovation has saved and improved countless lives. And there’s much more that can be achieved through innovation.

  • New cancer drugs increase survival rates.1

  • New medicines for heart disease and stroke now save over 1 million Americans a year.3
  • HIV deaths have declined by over 70% since the approval of combination therapy.4

The City paid for all services, including the counseling time of community pharmacists.

Patients who take newer medicines in place of older ones have a lower mortality rate.5*

Learn more about the importance of preserving an environment that rewards and encourages continued innovation.

* 5.5 years from FDA approval vs. 15 years

References:

  1. Lichtenberg FR. The Expanding Pharmaceutical Arsenal in the War on Cancer. National Bureau of Economic Research. Working Paper No. 10328. Cambridge, MA: NBER; 2004.
  2. American Cancer Society. Cancer Statistics 2007: A Presentation From the American Cancer Society. 2007.
  3. Kolata G. Gains on heart disease leave more survivors, and questions. New York Times (New York, NY). January 19, 2003. Available at http://www.nytimes.com/2003/01/19/us/gains-on-heart-disease-leave-more-survivors-and-questions.html. Accessed on April 14, 2010.
  4. Centers for Disease Control and Prevention. HIV Mortality Slides. Centers for Disease Control and Prevention Web site. Available at http://www.cdc.gov/hiv/topics/surveillance/resources/slides/mortality/index.htm. Accessed on October 5, 2010.
  5. Lichtenberg FR. The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Rico’s Medicaid Program. National Bureau of Economic Research. Working Paper No. 10884. Cambridge, MA: NBER; 2004.